In terms of Regulation 30 read with Schedule II Para A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, and in compliance with section 124 of the Companies Act, 2013, read with Rule 6 of the Investor Education And Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016, as amended, Jenburkt Pharmaceuticals has informed that it enclosed clippings of The Free Press Journal, Mumbai (English) and Navshakti, Mumbai (Marathi) dated 21st January, 2025, containing the newspaper advertisements published for giving Notice for transfer of dividend and corresponding equity shares of the Company to Investor Education and Protection Fund Authority. Copies of the above Newspaper Advertisement will also be made available on the website of the Company at www.jenburkt.com.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1735.45 |
Dr. Reddys Lab | 1144.05 |
Cipla | 1441.70 |
Lupin | 2026.50 |
Zydus Lifesciences | 885.70 |
View more.. |